Clinical trials show that two different drugs give patients two more years before their cancer metastasises. Read the article here.
PROSTATE CANCER: THE TWO DRUGS THAT CAN RADICALLY DELAY THE SPREAD OF THE DISEASE Read More »
Daily image-guided radiotherapy (IGRT) may reduce the rate of late rectal toxicity vs weekly therapy, according to research being presented at the 2018 Genitourinary Cancers Symposium in San Francisco, California. Daily IGRT was, however, also associated with a greater risk of secondary cancers and worse overall survival (OS). Read the article here.
Comparing Daily vs Weekly Image-Guided Radiotherapy for Prostate Cancer Read More »
Here are some recent blogs on Prostatepedia related to diet and exercise: Vitamin D, Omega-3 Fatty Acids, Curcumin + Prostate Cancer Diet + Lifestyle During Treatment Statins, Cholesterol + Prostate Cancer Exercise + Metastatic Prostate Cancer?
Prostatepedia Blog: Diet and Exercise Read More »
What seems (at least potentially) to be yet another major advance in the conduct of the radical prostatectomy — so-called Retzius-sparing radical prostatectomy. Read the article here.
Is Retzius-sparing radical prostatectomy the surgical wave of the future? Read More »
An excellent article on merits of surgery versus radiation done in two articles debate style. Makes a great summary for those looking to make a decision. Read the article here.
On a CureTalks conversation with Dr. Carl June of the University of Pennsylvania (UPenn), we learned that his team had very recently treated two men with metastatic, castration-resistant prostate cancer (mCRPC) using chimeric antibody receptor T-cell therapy (CAR-T). Read the article here.
CAR-T used in treatment of two men with mCRPC at UPenn Read More »
According to a news release just issued by Queen’s University, Belfast, a group of 150 researchers around the world is coming together to expand enrollment and access to the Australian INTERVAL trial into a global trial to test whether serious exercise should be prescribed as part of the treatment for men with advanced prostate cancer. Read the article.
Abiraterone acetate is poised to challenge docetaxel as the standard addition to androgen deprivation therapy for treatment of newly diagnosed, metastatic castration-resistant prostate cancer. Read the article here.
Success of abiraterone trials prompts ‘mind shift’ in prostate cancer treatment Read More »
Prostate cancer in men that was previously thought to be incurable could now be treated. New research has discovered that using a specialised form of radiotherapy could allow them to kill the disease off. Read the article here.
Prostate cancer breakthrough: New treatment could destroy INCURABLE tumours Read More »
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while protecting healthy tissue and reducing side effects. Read the article here.
Researchers reveal new approach to precisely identify and treat prostate cancer Read More »